O
GDRX icon

OrbiMed’s GoodRx Holdings GDRX Stock Holding History

OrbiMed’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,595,000
Closed -$8.98M – 122
2023
Q3 		$8.98M Sell
1,595,000
-193,600
-11% -$1.29M 0.19% 87
2023
Q2 		$9.87M Buy
1,788,600
+88,600
+5% +$477K 0.18% 86
2023
Q1 		$10.6M Buy
1,700,000
+1,312,433
+339% +$7.32M 0.21% 84
2022
Q4 		$1.81M Buy
+387,567
New +$1.91M 0.03% 104

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.94B AUM 9.49% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OrbiMed's GDRX Position: Q4 2023 in Review

OrbiMed sold out of GoodRx Holdings (GDRX) in Q4 2023, closing a stake of 1,595,000 shares — an estimated $8.98M sold.

OrbiMed first reported a position in GDRX in Q4 2022 and held it in 4 quarters. The position peaked at $10.6M in Q1 2023. 142 funds tracked by Wall St. Rank hold GDRX as of Q4 2023.

  • OrbiMed reported no remaining GoodRx Holdings position as of Q4 2023 after selling out during the quarter.
  • OrbiMed sold 1,595,000 GoodRx Holdings shares in Q4 2023, an estimated $8.98M.
  • OrbiMed first reported a position in GoodRx Holdings in Q4 2022 and held it in 4 quarters.
  • OrbiMed's GoodRx Holdings position peaked at $10.6M in Q1 2023.
  • 142 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2023.

Based on OrbiMed's 13F filing for Q4 2023, filed 14 Feb 2024.